Antisense Therapeutics Selected to Present at Biotech Showcase™ 2014 PR Newswire SAN FRANCISCO, Jan. 7, 2014 SAN FRANCISCO, Jan. 7, 2014 /PRNewswire/ -- Antisense Therapeutics Limited ("ANP" or...
Positive Results Achieved from Interim Analysis of ATL1103 Phase II Trial PR Newswire TOORAK, Australia, Dec. 23, 2013 TOORAK, Australia, Dec. 23, 2013 /PRNewswire/ -- Antisense Therapeutics...
ANP to present at and attend major US investment, partnering and industry conferences PR Newswire TOORAK, Australia, Aug. 28, 2013 TOORAK, Australia, Aug. 28, 2013 /PRNewswire/ -- Antisense...
Antisense Therapeutics Announces Launch of Level 1 American Depository Receipt Program Phase 2a Clinical Study for MS and Proof of Concept Study for Psoriasis Currently Underway MELBOURNE...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0.75 | 0.75 | 0.75 | 0 | 0 | DR |
26 | 0 | 0 | 0.75 | 0.75 | 0.75 | 0 | 0 | DR |
52 | 0 | 0 | 0.75 | 0.75 | 0.75 | 0 | 0 | DR |
156 | 0 | 0 | 0.75 | 0.75 | 0.75 | 0 | 0 | DR |
260 | 0 | 0 | 0.75 | 0.75 | 0.75 | 0 | 0 | DR |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約